Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.59
+0.04 (0.32%)
At close: Sep 12, 2025, 4:00 PM EDT
12.49
-0.10 (-0.79%)
After-hours: Sep 12, 2025, 4:10 PM EDT
Crescent Biopharma Employees
Crescent Biopharma had 6 employees as of December 31, 2024.
Employees
6
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$11,911,333
Market Cap
246.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CBIO News
- 16 days ago - Crescent Biopharma to Present at September Investor Conferences - GlobeNewsWire
- 26 days ago - Crescent Biopharma: Chasing The Summit Hype - Seeking Alpha
- 6 weeks ago - Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer - GlobeNewsWire
- 3 months ago - Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million - GlobeNewsWire
- 3 months ago - GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals - Business Wire
- 3 months ago - Crescent Biopharma to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 months ago - GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC - Business Wire